NCT05420207View on ClinicalTrials.gov

Implantable Long-Acting Pre-Exposure Prophylaxis For MSM

RecruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

June 14, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
HIV Prevention
Interventions
OTHER

No intervention

No intervention included

Trial Locations (2)

15261

RECRUITING

University of Pittsburgh, Pittsburgh

78712

ACTIVE_NOT_RECRUITING

Dell Medical School, UT-Austin, Austin

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Elizabeth Arnold

OTHER